Critics of the current corporate optometry model warn that the subordination of clinical judgment to commercial metrics poses a serious risk to patient safety. When optometrists are pressured to shorten consultation times or meet conversion targets, the primary goal of the appointment shifts from health detection to product sales. This creates a conflict of interest where the most vulnerable patients—such as the elderly or those with complex health needs—may be treated as revenue opportunities rather than individuals in need of thorough medical assessment.
The ethical concerns are compounded by the power imbalance between corporate management and individual practitioners. When a health professional is threatened with disciplinary action for failing to meet a sales quota, their ability to act in the best interest of the patient is severely compromised. This environment not only leads to moral distress among optometrists but also risks driving experienced professionals out of the industry, further exacerbating workforce shortages. The long-term consequence is a fragmented healthcare system where the quality of care is dictated by store budgets rather than clinical standards.
Accountability is also a major issue, as corporate entities often distance themselves from the specific sales pressures exerted by local franchise partners. This lack of transparency makes it difficult for regulators to intervene effectively. For the public, the risk is that serious, life-altering conditions—such as macular degeneration or early-stage tumors—could be missed if an optometrist is forced to rush through an exam to meet a store's hourly booking target. Ultimately, the health of the community should never be secondary to the financial performance of a retail chain.